Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Regimens in Resistant Lupus Nephritis
NCT01765842Phase 3Terminated
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Nov 2012
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in lupus nephritis (LN), sponsored by Andalusian Progress and Health Public Foundation. Started Nov 2012; status: terminated.
02
Drugs
rituximab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01765842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765842.